Enacts new GS 58-50-305 to require that if a health benefit plan provides coverage for prescription drugs, it must provide comparable coverage for opioid analgesic drugs whether they are abuse-deterrent (i.e., label indicating that the drug is expected to result in a meaningful reduction in abuse) or non-abuse-deterrent. Places a cap on cost sharing for these abuse-deterrent analgesics and prohibits plans from making certain changes to achieve compliance.
Prohibits plans from requiring an insured to use a non-abuse-deterrent analgesic before using an abuse-deterrent one. Provides that prior authorization requirements are allowed for both types of analgesics as long as the requirements are comparable. Effective October 1, 2015, and applies to contracts issued, renewed, or amended on or after that date.
ABUSE-DETERRENT OPIOID ANALGESICS.
Printer-friendly: Click to view
View NCGA Bill Details(link is external) | 2015-2016 Session |
AN ACT CONCERNING ABUSE-DETERRENT OPIOID ANALGESICS.Intro. by Malone, Horn.
Status: Re-ref Com On Insurance (House Action) (Apr 20 2015)
Bill History:
-
Tue, 14 Apr 2015 House: Filed(link is external)
-
Wed, 15 Apr 2015 House: Passed 1st Reading(link is external)
-
Mon, 20 Apr 2015 House: Withdrawn From Com(link is external)
-
Mon, 20 Apr 2015 House: Re-ref Com On Insurance(link is external)
H 744
Bill Summaries:
-
Bill H 744 (2015-2016)Summary date: Apr 15 2015 - View Summary
View: All Summaries for Bill